[Federal Register: November 6, 2009 (Volume 74, Number 214)]
[Notices]               
[Page 57460]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06no09-38]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Methods and 
Composition for Live Bubonic Plague Vaccine Based on Yersinia Pestis * 
* * Gene Deletion

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/242,113 entitled ``Methods and Composition for Live Bubonic Plague 
Vaccine Based On Yersinia Pestis * * * Gene Deletion,'' filed September 
14, 2009. The United States Government, as represented by the Secretary 
of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Assessment, (301) 619-6664, 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to the creation of 
live vaccines by removing a specific gene, which is essential for 
virulence (the ability of a pathogen to make sick or kill a human or an 
animal) from a pathogen.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E9-26790 Filed 11-5-09; 8:45 am]

BILLING CODE 3710-08-P